Genervon Will Present at Biotech Showcase Mechanisms of Actions of GM604 on 30 ALS Genes

Published: Jan 04, 2013

Genervon Biopharmaceuticals, LLC, a clinical stage biopharmaceutical company focused on neurodegenerative diseases, announced today that President and CEO, Winston Ko will present at the Biotech Showcase™ 2013 Conference being held in San Francisco on Tuesday (1/08/13) 10:45AM.

Back to news